» Articles » PMID: 38392786

A Quick ReCAP: Discovering Capsule Mutants

Overview
Journal J Fungi (Basel)
Date 2024 Feb 23
PMID 38392786
Authors
Affiliations
Soon will be listed here.
Abstract

is an opportunistic fungal pathogen that can cause severe meningoencephalitis in immunocompromised hosts and is a leading cause of death in HIV/AIDS patients. This pathogenic yeast is surrounded by a polysaccharide capsule that is critical for virulence and plays important roles in host-pathogen interactions. Understanding capsule biosynthesis is therefore key to defining the biology of and potentially discovering novel therapeutic targets. By exploiting methods to identify mutants deficient in capsule, June Kwon-Chung and other investigators have discovered numerous genes involved in capsule biosynthesis and regulation. Successful approaches have incorporated combinations of techniques including mutagenesis and systematic gene deletion; complementation and genetic screens; morphological examination, physical separation, and antibody binding; and computational modeling based on gene expression analysis. In this review, we discuss these methods and how they have been used to identify capsule mutants.

Citing Articles

Will the Real Immunogens Please Stand Up: Exploiting the Immunogenic Potential of Cryptococcal Cell Antigens in Fungal Vaccine Development.

Avina S, Pawar S, Rivera A, Xue C J Fungi (Basel). 2024; 10(12).

PMID: 39728336 PMC: 11676676. DOI: 10.3390/jof10120840.


Mechanisms and Virulence Factors of Dissemination to the Central Nervous System.

Al-Huthaifi A, Radman B, Al-Alawi A, Mahmood F, Liu T J Fungi (Basel). 2024; 10(8).

PMID: 39194911 PMC: 11355766. DOI: 10.3390/jof10080586.


Host immune response against fungal biofilms.

Mannan M, Nabeela S, Mishra R, Uppuluri P Curr Opin Microbiol. 2024; 81:102520.

PMID: 39126962 PMC: 11391915. DOI: 10.1016/j.mib.2024.102520.


Sac1 links phosphoinositide turnover to cryptococcal virulence.

Gaylord E, Choy H, Chen G, Briner S, Doering T mBio. 2024; 15(8):e0149624.

PMID: 38953635 PMC: 11323556. DOI: 10.1128/mbio.01496-24.

References
1.
Denning D . Global incidence and mortality of severe fungal disease. Lancet Infect Dis. 2024; 24(7):e428-e438. DOI: 10.1016/S1473-3099(23)00692-8. View

2.
Klutts J, Yoneda A, Reilly M, Bose I, Doering T . Glycosyltransferases and their products: cryptococcal variations on fungal themes. FEMS Yeast Res. 2006; 6(4):499-512. DOI: 10.1111/j.1567-1364.2006.00054.x. View

3.
Srikanta D, Yang M, Williams M, Doering T . A sensitive high-throughput assay for evaluating host-pathogen interactions in Cryptococcus neoformans infection. PLoS One. 2011; 6(7):e22773. PMC: 3145667. DOI: 10.1371/journal.pone.0022773. View

4.
OMeara T, Alspaugh J . The Cryptococcus neoformans capsule: a sword and a shield. Clin Microbiol Rev. 2012; 25(3):387-408. PMC: 3416491. DOI: 10.1128/CMR.00001-12. View

5.
Jacobson E, Ayers D, Harrell A, Nicholas C . Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans. J Bacteriol. 1982; 150(3):1292-6. PMC: 216353. DOI: 10.1128/jb.150.3.1292-1296.1982. View